A Suter

Optimal Cell Source for Cardiovascular Tissue Engineering: Venous vs. Aortic Human Myofibroblasts

A. Schnell, S HOERSTRUP, Gregor Zünd et al. · The Thoracic and Cardiovascular Surgeon · 2001 · 114 citations

Tissue Engineering, Aortic Human Myofibroblasts, Collagen Fibrils +25

A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan®) in the treatment of patients with congestive heart failure NYHA II

F. H. Degenring, A Suter, M Weber et al. · Phytomedicine · 2003 · 97 citations

Heart Failure, Cardiovascular Disease, Herbal Medicine +6

In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2

Johanna Signer, Hulda R. Jónsdóttir, Werner C. Albrich et al. · Virology Journal · 2020 · 88 citations · Full text

Safety and Efficacy Profile of<i>Echinacea purpurea</i>to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled Trial

M. Jawad, Roland Schoop, A Suter et al. · Evidence-based Complementary and Alternative Medicine · 2012 · 81 citations · Full text

Common Cold Episodes, Healthy Subjects, Herbal Medicine +9

Bioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune system

K Woelkart, Egon Marth, A Suter et al. · International Journal of Clinical Pharmacology and Therapeutics · 2006 · 74 citations

Medicinal Chemistry, Pharmacological Study, Adaptive Immune System +12